MENA: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in MENA

In 2023, the MENA's medicaments containing insulin market increased by X% to $X, rising for the second year in a row after three years of decline. Over the period under review, consumption, however, saw a deep downturn. As a result, consumption reached the peak level of $X. From 2017 to 2023, the growth of the market remained at a lower figure.

Medicaments Containing Insulin Production in MENA

In value terms, medicaments containing insulin production contracted to $X in 2023 estimated in export price. Overall, production, however, showed a relatively flat trend pattern. The growth pace was the most rapid in 2015 when the production volume increased by X%. The level of production peaked at $X in 2019; however, from 2020 to 2023, production remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Insulin Exports

Exports in MENA

In 2023, overseas shipments of medicaments containing insulin but not antibiotics increased by X% to X tons for the first time since 2020, thus ending a two-year declining trend. In general, exports, however, recorded a deep setback. The most prominent rate of growth was recorded in 2018 with an increase of X% against the previous year. Over the period under review, the exports reached the peak figure at X tons in 2013; however, from 2014 to 2023, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports surged to $X in 2023. Over the period under review, exports, however, faced a deep reduction. The pace of growth appeared the most rapid in 2020 when exports increased by X%. Over the period under review, the exports attained the peak figure at $X in 2012; however, from 2013 to 2023, the exports failed to regain momentum.

Exports by Country

In 2023, Jordan (X tons) was the largest exporter of medicaments containing insulin but not antibiotics, committing X% of total exports. It was distantly followed by the United Arab Emirates (X tons), making up a X% share of total exports. Turkey (X kg) held a minor share of total exports.

Jordan was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics exports, with a CAGR of X% from 2012 to 2023. Turkey (X%) and the United Arab Emirates (X%) illustrated a downward trend over the same period. While the share of Jordan (X p.p.) increased significantly in terms of the total exports from 2012-2023, the share of the United Arab Emirates (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United Arab Emirates ($X) emerged as the largest medicaments containing insulin supplier in MENA, comprising X% of total exports. The second position in the ranking was taken by Jordan ($X), with a X% share of total exports.

From 2012 to 2023, the average annual growth rate of value in the United Arab Emirates stood at X%. The remaining exporting countries recorded the following average annual rates of exports growth: Jordan (X% per year) and Turkey (X% per year).

Export Prices by Country

In 2023, the export price in MENA amounted to $X per ton, jumping by X% against the previous year. In general, the export price, however, saw a abrupt decline. The pace of growth was the most pronounced in 2016 when the export price increased by X%. As a result, the export price reached the peak level of $X per ton. From 2017 to 2023, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while Jordan ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (X%), while the other leaders experienced a decline in the export price figures.

Medicaments Containing Insulin Imports

Imports in MENA

After four years of decline, overseas purchases of medicaments containing insulin but not antibiotics increased by X% to X tons in 2023. Over the period under review, imports, however, saw a abrupt setback. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, imports hit record highs at X tons in 2016; however, from 2017 to 2023, imports failed to regain momentum.

In value terms, medicaments containing insulin imports surged to $X in 2023. Overall, imports, however, faced a abrupt curtailment. The growth pace was the most rapid in 2018 with an increase of X%. The level of import peaked at $X in 2016; however, from 2017 to 2023, imports failed to regain momentum.

Imports by Country

In 2023, Kuwait (X tons) was the largest importer of medicaments containing insulin but not antibiotics, generating X% of total imports. It was distantly followed by Tunisia (X tons), Egypt (X tons) and Iran (X tons), together mixing up a X% share of total imports.

Imports into Kuwait increased at an average annual rate of X% from 2012 to 2023. At the same time, Egypt (X%) displayed positive paces of growth. Moreover, Egypt emerged as the fastest-growing importer imported in MENA, with a CAGR of X% from 2012-2023. By contrast, Iran (X%) and Tunisia (X%) illustrated a downward trend over the same period. From 2012 to 2023, the share of Kuwait and Egypt increased by X and X percentage points, respectively.

In value terms, Egypt ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in MENA, comprising X% of total imports. The second position in the ranking was held by Kuwait ($X), with a X% share of total imports. It was followed by Tunisia, with a X% share.

From 2012 to 2023, the average annual rate of growth in terms of value in Egypt stood at X%. The remaining importing countries recorded the following average annual rates of imports growth: Kuwait (X% per year) and Tunisia (X% per year).

Import Prices by Country

In 2023, the import price in MENA amounted to $X per ton, increasing by X% against the previous year. In general, the import price, however, showed a relatively flat trend pattern. Over the period under review, import prices attained the peak figure at $X per ton in 2014; however, from 2015 to 2023, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Egypt ($X per ton), while Kuwait ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Egypt (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform